“This is John’s story. A true story. A day by day account of his life as told by himself in a series called – Emphysema Man. Proof positive that, with the exception of death and taxes, there are no guarantees in life.” Learn more about Emphysema: http://bit.ly/1ONmRdG…
Read the articles: 1. Idiopathic Pulmonary Fibrosis Trial to Test Combination of Existing Treatments 2. IPF Study Focuses on Patient and Caregiver Needs Beyond Treatment 3. IPF Patients Seen to Benefit from Pirfenidone Treatment…
“David Flurett was diagnosed with IPF – an incurable disease that causes scarring of the lungs. His doctors put him on a lung transplant list. On May 18, 2014 he received a lung transplant at MUSC.” Read more about Pulmonary Fibrosis: http://bit.ly/1lfMsiZ Learn more about Lung Transplants: http://bit.ly/1SNRT3u…
https://www.youtube.com/watch?v=FrPNIFjLgRw “Dr Toby Maher of the Royal Brompton Hospital, UK, talks about the impact of idiopathic pulmonary fibrosis (IPF) and the need to shed light on this ‘invisible disease’ .” Learn more about IPF:Â http://bit.ly/1QiRmr3…
New data from Phase 3 clinical studies of Genentech’s Esbriet (pirfenidone), a drug developed for the treatment of pulmonary fibrosis (PF), showed the treatment’s efficacy over time. The data presentation, the “Effect of continued treatment with pirfenidone following a clinically meaningful decline in percent predicted forced vital capacity…
“Donald used his own adult stem cells to treat his COPD. He was dealing with cardiologists and pulmonologists, but he just couldn’t see himself getting any better until he tried the stem cell treatment.” Learn more about Stem Cells: http://bit.ly/1Tw7AMJ…
PRM-151 is a recombinant human serum amyloid P/pentraxin 2 protein developed by Promedior, a biotechnology company developing therapies for fibrotic diseases using plasma-derived proteins and peptides. Also referred to as PTX2, the therapy is injected intravenously in patients and is showing promise as an effective anti-fibrotic agent which can be used to target several…
IPF is a progressive, fatal lung disease in which the alveoli and the lung tissue are damaged, becoming thick and scarred (fibrosis), leading to severe breathing difficulties and compromising oxygen transfer between the lungs and the bloodstream. IPF is characterized by a shortness of breath that gradually worsens,…
In this video from schoolofmedicine, meet Hamish S. Osborne and Christine C. Osborne. Mr. Osborne was diagnosed with IPF and had go to through surgery for a double-lung transplant. After that procedure, the couple became parte of the founding supporters of the Program in Lung Healing.
In a newly published paper in the Stem Cells Translational Medicine journal entitled Adult Lung Spheroid Cells Contain Progenitor Cells and Mediate Regeneration in Rodents With Bleomycin-Induced Pulmonary Fibrosis, scientists from North Carolina State University discovered a quick and simple method to produce stem cells from…
Get regular updates to your inbox.
